Debt - Narrative (Details)	Mar. 31, 2024 USD ($)	Mar. 15, 2024 USD ($)	Feb. 09, 2024 USD ($) day	Jun. 16, 2023 USD ($) $ / shares shares	Jun. 15, 2023 USD ($)	Jun. 09, 2023 USD ($)	Aug. 12, 2022 USD ($) $ / shares shares	Jun. 15, 2021 USD ($) $ / shares shares	Jun. 03, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 15, 2023	Nov. 16, 2023	May 11, 2023	Feb. 26, 2023	Jun. 09, 2021
Debt Instrument [Line Items]
Stock issued during period, reverse stock splits (in shares) | shares							115,000
Stock issued during period, reverse stock splits							$ 700,000
Total debt	$ 172,227,000									$ 172,227,000
Purchase agreement, remaining portion of the estimated cash consideration	139,000,000	$ 139,000,000
Debt, current	111,891,000									0
Debt, noncurrent	$ 37,268,000									$ 146,524,000
2025 Notes | Disposal Group, Not Discontinued Operations | Innovation Group
Debt Instrument [Line Items]
Net proceeds						0.20
2025 Notes | Convertible notes
Debt Instrument [Line Items]
Principal amount			$ 43,357,000				67,500,000
Proceeds from debt							22,500,000
Repayments of convertible debt					$ 10,300,000
Payments of debt issuance costs							$ 1,500,000
Convertible, shares issuable (in shares) | shares				3,270,114			3,857,142
Conversion price (in dollars per share) | $ / shares				$ 17.50			$ 17.50
Debt instrument, interest rate floor							10.50%
Effective interest rate	14.33%									14.38%	14.41%
Debt redemption, repurchase increment							$ 1,000
Debt repurchase, percentage of principal amount						100.00%	105.00%
Sale of assets, net proceeds threshold for repurchase							$ 15,000,000
Sale of assets, cash repurchase price as a percentage of net proceeds							20.00%
Sale of assets, net proceeds threshold, redemption price percentage							100.00%
Repurchased face amount						$ 10,300,000
Percentage of principal amount redeemed					15.20%
Total debt	$ 57,227,000			$ 57,200,000						$ 57,227,000
Premium percentage			0.0500
Previously held number of business days before deadline for timely performance | day			20
Current number of business days before deadline for timely performance | day			7
Supplemental indentures, principal amount outstanding percent			75.76%
2025 Notes | Convertible notes | Subsequent Event
Debt Instrument [Line Items]
Repurchased face amount									$ 19,700,000
Total debt									37,300,000
Unamortized debt issuance costs									$ 200,000
2025 Notes | Convertible notes | Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Basis spread on variable rate							9.00%
2026 Notes | Convertible notes
Debt Instrument [Line Items]
Principal amount			$ 86,329,000				$ 3,000,000	$ 160,000,000
Debt issuance costs							2,200,000	$ 8,100,000
Repayments of convertible debt							$ 45,000,000
Convertible, shares issuable (in shares) | shares							1,079,812	1,502,347
Conversion price (in dollars per share) | $ / shares							$ 106.50	$ 106.50
Debt repurchase, percentage of principal amount							100.00%
Sale of assets, cash repurchase price as a percentage of net proceeds			100.00%
Sale of assets, net proceeds threshold, redemption price percentage			100.00%
Total debt	115,000,000									115,000,000
Debt instrument, interest rate								6.25%							6.25%
Proceeds from issuance of long-term debt								$ 151,900,000
Fair value of derivative liability	$ 100,000									$ 100,000
Debt instrument, fact amount, per instrument							$ 2,000,000
Supplemental indentures, principal amount outstanding percent			75.07%
Cloudbreak Health, LLC.
Debt Instrument [Line Items]
Noncontrolling interest, ownership percentage by parent												100.00%
Innovations Group
Debt Instrument [Line Items]
Noncontrolling interest, ownership percentage by parent													100.00%	100.00%